Thomas Vranken

Financial Analyst (Pharma & Biotech)

Phone: +3224172554

Thomas Vranken holds a MSc in Bioscience Engineering from KU Leuven, complemented with a Specialized Masters business degree from ESCP Europe focusing on biopharmaceutical management.

He gained international experience in strategy and M&A analysis with positions at Alira Health and Bayer, and assessed early-stage investment opportunities for life sciences at Gimv. Thomas joined KBCS in 2021 from Roland Berger, where he worked as a strategy consultant focusing on investor support.